We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Review · January 25, 2022

Inhaled Levodopa May Have Benefit for Parkinson Disease

Neurology. Clinical Practice


Additional Info

Disclosure statements are available on the authors' profiles:

Neurology. Clinical Practice
Inhaled Levodopa (CVT-301) for the Treatment of Parkinson Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Neurol Clin Pract 2021 Dec 15;[EPub Ahead of Print], G Glenardi, T Handayani, J Barus, G Mangkuliguna

Further Reading